Influenza vaccine market

Renub Research www.renub.com Influenza Vaccines Market & Forecast Worldwide Analysis

United States…Japan…China…India Brazil…Netherlands…Germany…France Italy…Spain…Denmark…Sweden…Portugal Luxembourg…Lithuania…United Kingdom Poland…Norway…Romania…Estonia Finland…Hungary…Ireland…Iceland Latvia…Malta…Slovakia…Slovenia New Zealand…Australia

Published: November, 2014 © Renub Research

Page 1 of 21

Copyright © 2014 Renub Research – All Rights Reserved

Influenza Vaccines Market Analysis The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market.

Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic.

United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.

In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.

Renub

Research study

titled “Influenza Vaccines

Market

& Forecast

-

Worldwide

Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines Landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market 

Worldwide Influenza vaccines market (2009 - 2019)



Worldwide Seasonal Influenza vaccines market has been covered from (2009 – 2019)

© Renub Research

Page 2 of 21



Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 – 2011)



Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 2019)



Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)



Top 30 countries Seasonal Influenza vaccines market (2008 – 2019)



Top

Brands

Seasonal

Influenza

vaccines

(Fluarix/Flulaval,

Afluria/Fluvax,

FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast 

Top Merger & Acquisition deals in Influenza Vaccines Market



Key drivers of growth in the Worldwide Influenza Vaccines Market



Key challenges faces by Influenza Vaccines Market

All the 30 Countries Studied in the Report are as Follows 1. United States

11. Denmark

21. Finland

2. Japan

12. Sweden

22. Hungary

3. China

13. Portugal

23. Ireland

4. India

14. Luxembourg

24. Iceland

5. Brazil

15. Lithuania

25. Latvia

6. Netherlands

16. United Kingdom

26. Malta

7. Germany

17. Poland

27. Slovakia

8. France

18. Norway

28. Slovenia

9. Italy

19. Romania

29. Australia

10. Spain

20. Estonia

30. New Zealand

© Renub Research

Page 3 of 21

Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows

1. Fluarix / Flulaval 2. Afluria/Fluvax 3. FluMist/Fluenz 4. Influvac 5. Fluvirin / Flucelvax 6. Fluzone

Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Š Renub Research

Page 4 of 21

About Us Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at info@renub.com

Š Renub Research

Page 5 of 21

Published By

Renub Research 1st Floor, C-86, Sector–10 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com

© Influenza Vaccines Market & Forecast – Worldwide Analysis Renub Research, 2014 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers

© Renub Research

Page 6 of 21

Table of Contents 1.

Executive Summary

2.

Worldwide Influenza Vaccines Market & Forecast 2.1

Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

2.2

Merger and Acquisition in Influenza Vaccines Market

3.

Worldwide – Seasonal Influenza Vaccines Market & Forecast

4.

Worldwide – Swine Flu (H1N1) Influenza Vaccines Market

5.

Worldwide Influenza Vaccines Market Share & Forecast 5.1

Segment wise – Influenza Vaccines Market Share & Forecast

5.2

Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines

Share & Forecast 5.3 6.

Countries wise – Seasonal Influenza Vaccines Market Share & Forecast

Geographical Segmentation – Seasonal Influenza Vaccines Market & Vaccination Coverage

(2008 – 2019) 6.1

United States

6.1.1

United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.1.2

United States – Seasonal Influenza Vaccines Market & Forecast

6.2

Japan

6.2.1

Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.2.2

Japan – Seasonal Influenza Vaccines Market & Forecast

6.3

China

6.3.1

China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.3.2

China – Seasonal Influenza Vaccines Market & Forecast

6.4

India

6.4.1

India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.4.2

India – Seasonal Influenza Vaccines Market & Forecast

6.5

Brazil

6.5.1

Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.5.2

Brazil – Seasonal Influenza Vaccines Market & Forecast

6.6

Netherlands

© Renub Research

Page 7 of 21

6.6.1

Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.6.2

Netherlands – Seasonal Influenza Vaccines Market & Forecast

6.7

Germany

6.7.1

Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.7.2

Germany – Seasonal Influenza Vaccines Market & Forecast

6.8

France

6.8.1

France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.8.2

France – Seasonal Influenza Vaccines Market & Forecast

6.9

Italy

6.9.1

Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.9.2

Italy – Seasonal Influenza Vaccines Market & Forecast

6.10

Spain

6.10.1

Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.10.2

Spain – Seasonal Influenza Vaccines Market & Forecast

6.11

Denmark

6.11.1

Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.11.2

Denmark – Seasonal Influenza Vaccines Market & Forecast

6.12

Sweden

6.12.1

Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.12.2

Sweden – Seasonal Influenza Vaccines Market & Forecast

6.13

Portugal

6.13.1

Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.13.2

Portugal – Seasonal Influenza Vaccines Market & Forecast

6.14

Luxembourg

6.14.1

Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.14.2

Luxembourg – Seasonal Influenza Vaccines Market & Forecast

6.15

Lithuania

6.15.1

Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.15.2

Lithuania – Seasonal Influenza Vaccines Market & Forecast

6.16

United Kingdom

6.16.1

United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.16.2

United Kingdom – Seasonal Influenza Vaccines Market & Forecast

6.17

Poland

6.17.1

Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

© Renub Research

Page 8 of 21

6.17.2 6.18

Poland – Seasonal Influenza Vaccines Market & Forecast

Norway

6.18.1

Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.18.2

Norway – Seasonal Influenza Vaccines Market & Forecast

6.19

Romania

6.19.1

Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.19.2

Romania – Seasonal Influenza Vaccines Market & Forecast

6.20

Estonia

6.20.1

Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.20.2

Estonia – Seasonal Influenza Vaccines Market & Forecast

6.21

Finland

6.21.1

Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.21.2

Finland – Seasonal Influenza Vaccines Market & Forecast

6.22

Hungary

6.22.1

Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.22.2

Hungary – Seasonal Influenza Vaccines Market & Forecast

6.23

Ireland

6.23.1

Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.23.2

Ireland – Seasonal Influenza Vaccines Market & Forecast

6.24

Iceland

6.24.1

Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.24.2

Iceland – Seasonal Influenza Vaccines Market & Forecast

6.25

Latvia

6.25.1

Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.25.2

Latvia – Seasonal Influenza Vaccines Market & Forecast

6.26

Malta

6.26.1

Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.26.2

Malta – Seasonal Influenza Vaccines Market & Forecast

6.27

Slovakia

6.27.1

Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.27.2

Slovakia – Seasonal Influenza Vaccines Market & Forecast

6.28

Slovenia

6.28.1

Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.28.2

Slovenia – Seasonal Influenza Vaccines Market & Forecast

© Renub Research

Page 9 of 21

6.29

6.29.1

Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.29.2

Australia – Seasonal Influenza Vaccines Market & Forecast

6.30

7.

8.

Australia

New Zealand

6.30.1

New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.30.2

New Zealand – Seasonal Influenza Vaccines Market & Forecast

Worldwide – Seasonal Influenza Vaccine Brand Sales & Forecast 7.1

Fluarix / Flulaval – Sales Performance & Forecast

7.2

Afluria/Fluvax – Sales Performance & Forecast

7.3

FluMist/Fluenz – Sales Performance & Forecast

7.4

Influvac (Now Acquired by Abbott) – Sales Performance & Forecast

7.5

Fluvirin / Flucelvax – Sales Performance & Forecast

7.6

Fluzone – Sales Performance & Forecast

Growth Drivers in the Influenza Vaccines Market 8.1

Transforming Vaccine Technologies

8.2

Continuous Focus on Effective Communication Strategies

8.3

Vaccines most Cost Effective Means of Disease Prevention

8.4

Scientific & Technological Breakthroughs

8.5

Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in

European Countries 9.

Challenges for Influenza Vaccine Market 9.1

Obstacle to Best Possible use of Licensed Vaccines

9.1.1

Economic Obstacles

9.1.2

Technical Obstacles

9.1.3

Cultural Obstacles

9.2

Difficulty of Influenza Vaccine Development & Approval System

9.2.1

General Technical Barriers

9.2.2

Economic Barriers

9.2.3

Legal Barriers

9.2.4

Regulatory Barriers

9.3

Reducing the Timeline for Vaccine Development

© Renub Research

Page 10 of 21

9.4

Problem Faced by Healthcare Workers in Immunization

Š Renub Research

Page 11 of 21

List of Figures

Figure 2-1: Worldwide – Influenza Vaccines Market (Million US$), 2009 – 2013 Figure 2-2: Worldwide – Forecast for Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 2-3: Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2009 – 2013 Figure 2-4: Worldwide – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2014 – 2019 Figure 3-1: Worldwide – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013 Figure 3-2: Worldwide – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 4-1: Worldwide – Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 – 2011 Figure 5-1: Segment wise – Influenza Vaccines Market Share (Percent), 2009 – 2013 Figure 5-2: Segment wise – Forecast for Influenza Vaccines Market Share (Percent), 2014 – 2019 Figure 6-1: United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2009 – 2013 Figure 6-2: United States – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-3: United States – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013 Figure 6-4: United States – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-5: Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-6: Japan – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-7: Japan – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-8: Japan – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-9: China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013 Figure 6-10: China – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-11: China – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-12: China – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-13: India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-14: India – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-15: India – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-16: India – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 © Renub Research

Page 12 of 21

Figure 6-17: Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-18: Brazil – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-19: Brazil – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-20: Brazil – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-21: Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-22: Netherlands – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-23: Netherlands – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-24: Netherlands – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-25: Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-26: Germany – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-27: Germany – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-28: Germany – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-29: France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-30: France – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-31: France – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-32: France – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-33: Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-34: Italy – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-35: Italy – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-36: Italy – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-37: Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-38: Spain – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-39: Spain – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-40: Spain – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research

Page 13 of 21

Figure 6-41: Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-42: Denmark – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-43: Denmark – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-44: Denmark – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-45: Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-46: Sweden – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-47: Sweden – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-48: Sweden – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-49: Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-50: Portugal – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-51: Portugal – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-52: Portugal – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-53: Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-54: Luxembourg – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-55: Luxembourg – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-56: Luxembourg – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-57: Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-58: Lithuania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-59: Lithuania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-60: Lithuania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-61: United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-62: United Kingdom – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-63: United Kingdom – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-64: United Kingdom – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research

Page 14 of 21

Figure 6-65: Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-66: Poland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-67: Poland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-68: Poland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-69: Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-70: Norway – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-71: Norway – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-72: Norway – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-73: Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-74: Romania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-75: Romania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-76: Romania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-77: Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-78: Estonia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-79: Estonia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-80: Estonia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-81: Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-82: Finland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-83: Finland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-84: Finland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-85: Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-86: Hungary – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-87: Hungary – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-88: Hungary – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research

Page 15 of 21

Figure 6-89: Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013 Figure 6-90: Ireland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-91: Ireland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-92: Ireland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-93: Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-94: Iceland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-95: Iceland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-96: Iceland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-97: Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-98: Latvia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-99: Latvia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-100: Latvia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-101: Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-102: Malta – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-103: Malta – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-104: Malta – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-105: Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-106: Slovakia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-107: Slovakia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-108: Slovakia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-109: Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-110: Slovenia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-111: Slovenia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-112: Slovenia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research

Page 16 of 21

Figure 6-113: Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-114: Australia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-115: Australia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-116: Australia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 6-117: New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013 Figure 6-118: New Zealand – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019 Figure 6-119: New Zealand – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013 Figure 6-120: New Zealand – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019 Figure 7-1: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 – 2013 Figure 7-2: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019 Figure 7-3: Worldwide – Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 – 2013 Figure 7-4: Worldwide – Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019 Figure 7-5: Worldwide – Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013 Figure 7-6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019 Figure 7-7: Worldwide – Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 – 2009 Figure 7-8: Worldwide – Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 – 2013 Figure 7-9: Worldwide – Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019 Figure 7-10: Worldwide – Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013 Figure 7-11: Worldwide – Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019

© Renub Research

Page 17 of 21

List of Tables

Table 2-1: Worldwide – Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 – 2011 Table 5-1: Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2009 – 2013 Table 5-2: Countries wise – Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2014 – 2019 Table 5-3: Countries wise – Seasonal Influenza Vaccines Market Share (Percent), 2009 – 2013 Table 5-4: Countries wise – Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 – 2019 Table 8-1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations Table 8-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009

© Renub Research

Page 18 of 21

Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call

+91-120-421-9822 (India),

+1-678-302-0700

(USA)

or

mail

info@renub.com

Format Report Title: Influenza Vaccines Market & Forecast - Worldwide Analysis

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,490

US$ 1,640

US$ 1,590

US$ 2,490

For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/influenza-vaccines-market-forecast---worldwide-analysis-151 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=151&pid=1574

To pay by Wire Transfer, please, fill in your contact details in the form below:

Š Renub Research

Page 19 of 21

to

Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India

Contact Information First Name:

Last Name:

Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:

© Renub Research

Page 20 of 21

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor C-86, Sector -10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Š Renub Research

Page 21 of 21